Gujarat Terce Laboratories opened lower at -, compared with its previous close of ₹43.00. During today's session, the stock has traded between - and -, with an average traded price of -. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Gujarat Terce Laboratories is now worth
₹ 23,243.00
Giving a profit of
₹ 13,243.00 (132.43%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹43.00
Volume
-
Value Traded
-
1W Return
-7.86%
1M Return
3.51%
3M Return
10.17%
6M Return
22.86%
1Y Return
-2.38%
Market Cap (₹ Cr.)
34
PE Ratio
16.70
PB Ratio
3.08
Dividend Yield
-
ROE
22.63%
ROCE
23.61%
Book Value (₹)
13.95
Face Value (₹)
10.00
EPS (TTM)
0.61
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-7.86%
6 Weeks
-
1 Month
3.51%
3 Months
10.17%
9 Months
4.09%
No data available.
Gujarat Terce Laboratories Q2FY27 net profit dips 6% to ₹1.32 crore
Q2FY27 net profit declined 6.01% YoY to ₹1.32 crore. Revenue from operations contracted 1.15% YoY to ₹12.78 crore. H1FY27 net profit dropped to ₹1.14 crore due to Q1 loss. Reserves surged to ₹3.08 crore in H1FY27 from ₹0.07 crore in H1FY26.
6 days agoGujarat Terce Labs buys Ahmedabad office premises for ₹3.23 crore
Gujarat Terce Laboratories purchased 'Swati18' office premises in Ahmedabad for ₹3.23 crore. The property covers 2,012.20 sq ft and is located beside Palladium Mall, S.G. Highway. Counterparty is Swatisandhya Procon LLP; the deal is not a related party transaction. Purchase price excludes taxes, stamp duty, and registration fees.
7 days agoGujarat Terce Labs secures unanimous vote for MD re-appointment at AGM
Gujarat Terce Laboratories secured 100% approval for all resolutions at its 41st AGM. Total votes polled were 3,470,935 out of 7,791,300 shares, a 44.55% participation rate. Aalap Prajapati re-appointed as MD & CEO for three years, ending October 27, 2029. Natwarbhai Prajapati re-appointed as director liable to retire by rotation. Company corrected earlier filing to clarify Prajapati's tenure is three years, not five.
2mo agoGujarat Terce Laboratories Q1 Results: Net Loss Widens To ₹17.81 Lakh
Gujarat Terce Laboratories Ltd posted a Q1FY27 net loss of ₹17.81 lakh, worsening from ₹4.35 lakh in Q1FY26. Revenue fell 17.1% YoY to ₹900.24 lakh. While material costs dropped significantly to ₹13.51 lakh, high employee benefits and other expenses kept total costs at ₹963.35 lakh. Statutory auditors Shah Doshi Patel & Associates LLP provided an unmodified limited review.
3mo agoGujarat Terce Laboratories Q1 Results: Net profit rises 12% YoY to ₹205 crore
Gujarat Terce Laboratories posted a Q1FY26 consolidated net profit of ₹205.41 crore, up 12.3% YoY, driven by a 27.6% rise in revenue to ₹4,170.47 crore. The company also scheduled its 41st AGM for August 21, 2026, with e-voting facilities available from August 18 to 20.
3mo agoGujarat Terce Labs returns to profitability in FY26 with net profit of ₹220.17 lakh
Gujarat Terce Laboratories Limited returned to profitability in FY26 with a net profit of ₹220.17 lakh, compared to a loss of ₹97.87 lakh in the previous year. Revenue from operations decreased to ₹4747.27 lakh from ₹5019.52 lakh in FY25. The company's EBITDA improved to ₹363 lakh, and net worth grew by over 50%, supported by improved earnings and a stronger capital structure.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,899.30 | +0.76% | ₹4,55,705.69 | 41.20 | +9.65% | |
| ₹11,495.00 | +0.09% | ₹3,05,156.13 | 90.40 | +76.30% | |
| ₹4,685.20 | -0.89% | ₹1,78,209.95 | 85.50 | +22.50% | |
| ₹2,427.00 | +1.13% | ₹1,31,133.78 | 97.10 | +145.34% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.30 | +0.12% | ₹1,15,878.66 | 42.00 | +12.91% | |
| ₹1,409.80 | +0.11% | ₹1,13,891.88 | 39.90 | -7.21% | |
| ₹2,663.30 | +0.94% | ₹1,10,006.30 | 48.10 | +17.33% | |
| ₹1,808.90 | +0.09% | ₹1,04,080.11 | 26.00 | +52.83% | |
| ₹2,019.10 | +0.20% | ₹92,331.42 | 17.60 | -0.73% | |
| ₹2,639.00 | -0.78% | ₹74,479.09 | 51.60 | +42.82% | |
| ₹5,194.00 | -2.04% | ₹62,102.06 | 30.50 | -9.94% |
An investment of ₹10,000 made 5 years ago in Gujarat Terce Laboratories is now worth
₹ 23,243.00
Giving a profit of
₹ 13,243.00 (132.43%)
Note: Past profits do not guarantee future returns.
